Shedir Pharma Group Statistics

Total Valuation

Shedir Pharma Group has a market cap or net worth of EUR 55.45 million. The enterprise value is 52.75 million.

Market Cap	55.45M
Enterprise Value	52.75M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Shedir Pharma Group has 11.36 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	11.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	88.01%
Owned by Institutions (%)	0.73%
Float	1.36M

Valuation Ratios

The trailing PE ratio is 9.30 and the forward PE ratio is 8.87.

PE Ratio	9.30
Forward PE	8.87
PS Ratio	0.91
PB Ratio	1.48
P/TBV Ratio	1.71
P/FCF Ratio	8.80
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.23, with an EV/FCF ratio of 8.37.

EV / Earnings	8.79
EV / Sales	0.87
EV / EBITDA	4.23
EV / EBIT	6.04
EV / FCF	8.37

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.16.

Current Ratio	2.86
Quick Ratio	1.51
Debt / Equity	0.16
Debt / EBITDA	0.47
Debt / FCF	0.93
Interest Coverage	34.96

Financial Efficiency

Return on equity (ROE) is 17.54% and return on invested capital (ROIC) is 12.91%.

Return on Equity (ROE)	17.54%
Return on Assets (ROA)	9.70%
Return on Capital (ROIC)	12.91%
Revenue Per Employee	725,726
Profits Per Employee	71,421
Employee Count	79
Asset Turnover	1.08
Inventory Turnover	2.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.91% in the last 52 weeks. The beta is 0.72, so Shedir Pharma Group's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+9.91%
50-Day Moving Average	4.84
200-Day Moving Average	4.08
Relative Strength Index (RSI)	66.91
Average Volume (20 Days)	6,138

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shedir Pharma Group had revenue of EUR 60.96 million and earned 6.00 million in profits. Earnings per share was 0.52.

Revenue	60.96M
Gross Profit	18.91M
Operating Income	8.74M
Pretax Income	8.59M
Net Income	6.00M
EBITDA	11.12M
EBIT	8.74M
Earnings Per Share (EPS)	0.52

Full Income Statement

Balance Sheet

The company has 8.71 million in cash and 5.88 million in debt, giving a net cash position of 2.84 million or 0.25 per share.

Cash & Cash Equivalents	8.71M
Total Debt	5.88M
Net Cash	2.84M
Net Cash Per Share	0.25
Equity (Book Value)	37.72M
Book Value Per Share	3.31
Working Capital	28.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.37 million and capital expenditures -3.07 million, giving a free cash flow of 6.30 million.

Operating Cash Flow	9.37M
Capital Expenditures	-3.07M
Free Cash Flow	6.30M
FCF Per Share	0.55

Full Cash Flow Statement

Margins

Gross margin is 31.02%, with operating and profit margins of 14.34% and 9.96%.

Gross Margin	31.02%
Operating Margin	14.34%
Pretax Margin	14.09%
Profit Margin	9.96%
EBITDA Margin	18.25%
EBIT Margin	14.34%
FCF Margin	10.34%

Dividends & Yields

Shedir Pharma Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	10.76%
FCF Yield	11.37%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shedir Pharma Group has an Altman Z-Score of 3.69.

Altman Z-Score	3.69
Piotroski F-Score	n/a